2,043
Views
6
CrossRef citations to date
0
Altmetric
Articles

Clinical efficacy of systemic chemotherapy combined with radiofrequency ablation and microwave ablation for lung cancer: a comparative study

, , , , , & show all
Pages 900-906 | Received 09 Jan 2021, Accepted 24 May 2021, Published online: 21 Jun 2021

Reference

  • Dane B, Grechushkin V, Plank A, et al. PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer. Am J Nucl Med Mol Imaging. 2013;3:408–416.
  • She K, Yan H, Huang J, et al. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer. Cell Prolif. 2018;51(1):12406.
  • Palussiere J, Chomy F, Savina M, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg. 13(1):91. 2018;13:91.
  • Nagasaka M, Gadgeel SM. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer. Expert Rev Anticancer Ther. 2018;18:63–70.
  • de Baere T, Tselikas L, Catena V, et al. Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging. 2016;97:1019–1024.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260.
  • Donington JS. Radiofrequency ablation in high-risk stage I non-small cell lung cancer. Cancer. 2015;121:3393–3394.
  • Murphy KP, Maher MM, O'Connor OJ. Abdominal ablation techniques. AJR Am J Roentgenol. 2015;204:W495–502.
  • An C, Li WZ, Huang ZM, et al. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. Eur Radiol. 2021. DOI:https://doi.org/10.1007/s00330-020-07571-5
  • Wei Z, Yang X, Ye X, et al. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol. 2020;30(5):2692–2702.
  • Palussiere J, Catena V, Lagarde P, et al. Primary tumors of the lung: should we consider thermal ablation as a valid therapeutic option? Int J Hyperthermia. 2019;36:46–52.
  • Sone K, Oguri T, Ito K, et al. Predictive role of CYFRA21-1 and CEA for subsequent docetaxel in non-small cell lung cancer patients. Anticancer Res. 2017;37:5125–5131.
  • Ye X, Fan W, Wang H, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6:112–121.
  • Cheng M, Fay M, Steinke K. Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: a retrospective study. Int J Hyperthermia. 2016;32(3):316–323.
  • Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543.
  • Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–763.
  • Wei Z, Ye X, Yang X, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2015;38:135–142.
  • Wei Z, Ye X, Yang X, et al. Advanced non small cell lung cancer: response to microwave ablation and EGFR Status. Eur Radiol. 2017;27:1685–1694.
  • Wei Z, Ye X, Yang X, et al. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol. 2015;32:464.
  • Du S, Qin D, Pang R, et al. Long-term efficacy of radiofrequency ablation combined with chemotherapy in the treatment of patients with advanced non-small cell lung cancer–a retrospective study. Zhongguo Fei Ai Za Zhi. 2017;20:675–682.
  • Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66:1172–1173.
  • Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol. 2017;34(5):96.
  • Planche O, Teriitehau C, Boudabous S, et al. In vivo evaluation of lung microwave ablation in a porcine tumor mimic model. Cardiovasc Intervent Radiol. 2013;36:221–228.
  • Lucchina N, Tsetis D, Ierardi AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol. 2016;29:460–465.
  • Yao W, Lu M, Fan W, et al. Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis. Int J Hyperthermia. 2018;34:1329–1336.